Edition:
United States

Orion Oyj (ORNAV.HE)

ORNAV.HE on Helsinki Stock Exchange

30.60EUR
11:59am EDT
Change (% chg)

€-0.40 (-1.29%)
Prev Close
€31.00
Open
€31.00
Day's High
€31.00
Day's Low
€30.60
Volume
3,541
Avg. Vol
7,019
52-wk High
€42.38
52-wk Low
€24.75

Chart for

About

Orion Oyj is a Finland-based company engaged in the development, manufacture and marketing of pharmaceuticals and diagnostic tests. The Company operates, along with its subsidiaries, in two business segments: the Pharmaceuticals business segment develops, manufactures and markets pharmaceuticals and active pharmaceutical... (more)

Overall

Beta: 0.75
Market Cap(Mil.): €4,272.82
Shares Outstanding(Mil.): 141.26
Dividend: 1.45
Yield (%): 4.67

Financials

  ORNAV.HE Industry Sector
P/E (TTM): 21.65 28.28 30.39
EPS (TTM): 1.43 -- --
ROI: 26.80 12.94 12.61
ROE: 32.19 14.96 14.80

BRIEF-Orion Oyj to sell its Orion Diagnostica division

* REG-ORION TO SELL ITS ORION DIAGNOSTICA DIVISION - DUE TO THE TRANSACTION ORION UPDATES ITS OUTLOOK

Apr 20 2018

BRIEF-Orion Updates Primary Completion Date Of Phase III To September 2018

* STATUS UPDATE OF THE PHASE III ARAMIS CLINICAL TRIAL WITH DAROLUTAMIDE IN PATIENTS WITH NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER

Apr 03 2018

BRIEF-Orion: Positive Conclusions For Salmeterol-Fluticasone Easyhaler Combination Under EU's Decentralized Procedures

* ORION HAS RECEIVED POSITIVE CONCLUSIONS FOR THE SALMETEROL-FLUTICASONE EASYHALER® COMBINATION UNDER THE EU'S DECENTRALIZED PROCEDURES

Mar 19 2018

BRIEF-Orion Conducts Personnel Reduction of 17 Positions

* ‍17 PERSONS OF COMPANY'S PERSONNEL WILL BE GIVEN A NOTICE.​

Feb 28 2018

Earnings vs. Estimates